Javascript must be enabled to continue!
Acetate as a metabolic booster for glucose-based bioproduction in Escherichia coli
View through CrossRef
Abstract
Escherichia coli
, a key workhorse in industrial biotechnology, is commonly grown on glucose, which supports rapid growth but leads to acetate overflow, which instead inhibits growth, diverts carbon from the production pathway, and reduces productivity. Recent studies suggest that acetate may also have beneficial effects in glucose-grown
E. coli
, but its potential in bioprocesses remains unexplored. In this study, we systematically investigated acetate’s impact on bioproduction using a kinetic model of glucose and acetate metabolism in
E. coli
. The model predicts that acetate can enhance bioproduction in glucose-grown
E. coli
through three mechanisms: (i) by minimizing acetate overflow, thereby reducing carbon loss, (ii) by increasing acetyl-CoA levels, thereby boosting the biosynthetic flux of acetyl-CoA-derived compounds, and (iii) by promoting biomass accumulation, thus improving overall productivity. We experimentally validated the predictions of the model for mevalonate and 3-hydroxypropionate production, where acetate supplementation increased productivity by 117% and 34%, respectively. Our findings provide a valuable framework for optimizing
E. coli
-based bioprocesses and highlight acetate’s underutilized potential in biotechnology. By leveraging acetate from waste streams as a metabolic booster, this approach could contribute to more sustainable and environmentally friendly bioprocesses.
Highlights
-
A kinetic model was used for rational optimization of
E. coli
-based bioprocesses
-
Acetate can enhance growth and production of acetyl-CoA-derived bioproducts
-
Model predictions were validated for mevalonate and 3-hydroxypropionate production
-
Acetate can be used as a metabolic booster for glucose-based bioproduction in
E. coli
Title: Acetate as a metabolic booster for glucose-based bioproduction in Escherichia coli
Description:
Abstract
Escherichia coli
, a key workhorse in industrial biotechnology, is commonly grown on glucose, which supports rapid growth but leads to acetate overflow, which instead inhibits growth, diverts carbon from the production pathway, and reduces productivity.
Recent studies suggest that acetate may also have beneficial effects in glucose-grown
E.
coli
, but its potential in bioprocesses remains unexplored.
In this study, we systematically investigated acetate’s impact on bioproduction using a kinetic model of glucose and acetate metabolism in
E.
coli
.
The model predicts that acetate can enhance bioproduction in glucose-grown
E.
coli
through three mechanisms: (i) by minimizing acetate overflow, thereby reducing carbon loss, (ii) by increasing acetyl-CoA levels, thereby boosting the biosynthetic flux of acetyl-CoA-derived compounds, and (iii) by promoting biomass accumulation, thus improving overall productivity.
We experimentally validated the predictions of the model for mevalonate and 3-hydroxypropionate production, where acetate supplementation increased productivity by 117% and 34%, respectively.
Our findings provide a valuable framework for optimizing
E.
coli
-based bioprocesses and highlight acetate’s underutilized potential in biotechnology.
By leveraging acetate from waste streams as a metabolic booster, this approach could contribute to more sustainable and environmentally friendly bioprocesses.
Highlights
-
A kinetic model was used for rational optimization of
E.
coli
-based bioprocesses
-
Acetate can enhance growth and production of acetyl-CoA-derived bioproducts
-
Model predictions were validated for mevalonate and 3-hydroxypropionate production
-
Acetate can be used as a metabolic booster for glucose-based bioproduction in
E.
coli.
Related Results
Cost-Effectiveness Analysis of COVID-19 Vaccine Booster Dose in the Thai Setting during the Period of Omicron Variant Predominance
Cost-Effectiveness Analysis of COVID-19 Vaccine Booster Dose in the Thai Setting during the Period of Omicron Variant Predominance
The Thai government implemented COVID-19 booster vaccines to prevent morbidity and mortality during the spreading of the Omicron variant. However, little is known about which types...
Cost effectiveness analysis comparing varying booster intervals of vaccination policies to address COVID-19 situation in Thailand, 2023
Cost effectiveness analysis comparing varying booster intervals of vaccination policies to address COVID-19 situation in Thailand, 2023
The COVID-19 booster immunization policy is cost-effective, but evidence on additional booster doses and appropriate strategies is scarce. This research compared the cost-effective...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Abstract
Introduction
During pregnancy, women may develop blood glucose abnormalities like gestational diabetes mellitus (GDM) or, rarely, type 1 diabetes (T1D), which can lead to ...
Abstract P2-20-01: Safety and Clinical Efficacy of Multiple Booster Inoculations with the E75 Adjuvant Breast Cancer Vaccine
Abstract P2-20-01: Safety and Clinical Efficacy of Multiple Booster Inoculations with the E75 Adjuvant Breast Cancer Vaccine
Abstract
Background: We are conducting clinical trials of the HER2/neu E75-peptide+GM-CSF vaccine in clinically disease-free breast cancer patients at high risk for ...
Acceptance of COVID-19 Booster in the adult population of Pakistan: A cross sectional study
Acceptance of COVID-19 Booster in the adult population of Pakistan: A cross sectional study
Abstract
Background: A year after the COVID-19 pandemic vaccination rollout, vaccine elicited immunity is waning and newer variants e.g. The Delta Variants and Omicron have...
Diarrhoeagenic Escherichia coli isolated from children with acute diarrhoea at Rakai hospital, Southern Uganda
Diarrhoeagenic Escherichia coli isolated from children with acute diarrhoea at Rakai hospital, Southern Uganda
Background: Diarrhoeagenic Escherichia coli (DEC) is a leading cause of childhood diarrhoea. This study estimated the prevalence of DEC and DEC pathotypes among children with acute...
Second Booster Vaccine and Covid-19 Mortality in Adults 60 to 100 Years Old
Second Booster Vaccine and Covid-19 Mortality in Adults 60 to 100 Years Old
Abstract
The rapid emergence of the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus-2 led to a global resurgence of coronavirus disease 2019 (C...

